120 related articles for article (PubMed ID: 7942701)
1. Monoclonal antibody imaging in colon cancer: a transition from basic science to clinical application.
Kim SL; Goldschmid S
Am J Gastroenterol; 1994 Oct; 89(10):1910-2. PubMed ID: 7942701
[No Abstract] [Full Text] [Related]
2. OncoScint CR103 imaging in the surgical management of patients with colorectal cancer.
Doerr RJ; Abdel-Nabi HH
Targeted Diagn Ther; 1992; 6():89-109. PubMed ID: 1576352
[No Abstract] [Full Text] [Related]
3. Oncoscint for detection of disseminated colorectal and ovarian cancer.
Med Lett Drugs Ther; 1993 Jun; 35(898):52-3. PubMed ID: 8497207
[No Abstract] [Full Text] [Related]
4. OncoScint image atlas.
Maguire RT
Targeted Diagn Ther; 1992; 6():141-75. PubMed ID: 1576344
[No Abstract] [Full Text] [Related]
5. Radioimmunodetection of colorectal carcinoma.
Artiko V; Obradovic V; Davidovic B; Petrovic N; Petrovic M; Krivokapic Z; Kecmanovic D; Pesko P; Djukic V; Milosavljevic T; Adanja G; Vlajkovic M
Hepatogastroenterology; 2003; 50(52):1029-31. PubMed ID: 12845972
[TBL] [Abstract][Full Text] [Related]
6. Results of immunoscintigraphy using a cocktail of radiolabeled monoclonal antibodies in the detection of colorectal cancer.
Volpe CM; Abdel-Nabi HH; Kulaylat MN; Doerr RJ
Ann Surg Oncol; 1998 Sep; 5(6):489-94. PubMed ID: 9754756
[TBL] [Abstract][Full Text] [Related]
7. Immunoscintigraphy performed with In-111-labeled CYT-103 in the management of colorectal cancer: comparison with CT.
Collier BD; Abdel-Nabi H; Doerr RJ; Harwood SJ; Olsen J; Kaplan EH; Winzelberg GG; Grossman SJ; Krag DN; Mitchell EP
Radiology; 1992 Oct; 185(1):179-86. PubMed ID: 1523304
[TBL] [Abstract][Full Text] [Related]
8. Multicenter clinical trials of monoclonal antibody B72.3-GYK-DTPA 111In (111In-CYT-103; OncoScint CR103) in patients with colorectal carcinoma.
Abdel-Nabi HH; Doerr RJ
Targeted Diagn Ther; 1992; 6():73-88. PubMed ID: 1576351
[TBL] [Abstract][Full Text] [Related]
9. [Indium 111-labeled antibodies in the detection of colorectal carcinoma].
Artiko V; Obradović V; Davidović B; Petrović N; Petrović M; Krivokapić Z; Pavlov M; Adanja G; Sobić D; Vlajković M; Pavlović S; Rebić R
Acta Chir Iugosl; 2003; 50(4):43-6. PubMed ID: 15307496
[TBL] [Abstract][Full Text] [Related]
10. [Immunoscintigraphy of prostatic cancer].
Aliaev IuG; Vinarov AZ; Rapoport LM; Bezrukov EA; Butnaru DV
Urologiia; 2006; (4):67-9. PubMed ID: 17058687
[No Abstract] [Full Text] [Related]
11. Use of the radiolabeled murine monoclonal antibody, 111In-CYT-103, in the management of colon cancer.
Petersen BM; Bass BL; Bates HR; Chandeysson PL; Harmon JW
Am J Surg; 1993 Jan; 165(1):137-42; discussion 142-3. PubMed ID: 8418688
[TBL] [Abstract][Full Text] [Related]
12. Multicenter clinical trial of 111In-CYT-103 in patients with ovarian cancer.
Gallup DG
Targeted Diagn Ther; 1992; 6():111-24. PubMed ID: 1576342
[No Abstract] [Full Text] [Related]
13. Radioimmunoguided surgery of colorectal carcinoma with an 111In-labelled anti-TAG72 monoclonal antibody.
Muxi A; Pons F; Vidal-Sicart S; Setoain FJ; Herranz R; Novell F; Fernandez RM; Trias M; Setoain J
Nucl Med Commun; 1999 Feb; 20(2):123-30. PubMed ID: 10088160
[TBL] [Abstract][Full Text] [Related]
14. 111In-CYT-103 scanning in recurrent colorectal cancer--does it affect standard management?
Dominguez JM; Wolff BG; Nelson H; Forstrom LA; Mullan BP
Dis Colon Rectum; 1996 May; 39(5):514-9. PubMed ID: 8620800
[TBL] [Abstract][Full Text] [Related]
15. A practical approach to planar and SPECT imaging of 111In-CYT-103.
Collier BD; Trembath LA; Liu Y; Turoglu HT; Patel N; Thakur S
Targeted Diagn Ther; 1992; 6():191-210. PubMed ID: 1576346
[No Abstract] [Full Text] [Related]
16. Indium-111 monoclonal antibody B72.3 scintigraphy in colorectal cancer. Correlation with computed tomography, surgery, histopathology, immunohistology, and human immune response.
Winzelberg GG; Grossman SJ; Rizk S; Joyce JM; Hill JB; Atkinson DP; Sudina K; Anderson K; McElwain D; Jones AM
Cancer; 1992 Apr; 69(7):1656-63. PubMed ID: 1551051
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience with radiolabelled monoclonal antibodies in the detection of colorectal and ovarian carcinoma recurrence and review of the literature.
Pinkas L; Robins PD; Forstrom LA; Mahoney DW; Mullan BP
Nucl Med Commun; 1999 Aug; 20(8):689-96. PubMed ID: 10451876
[TBL] [Abstract][Full Text] [Related]
18. Impact of 111In-CYT-103 on the surgical management of patients with ovarian cancer.
Surwit EA
Targeted Diagn Ther; 1992; 6():125-40. PubMed ID: 1576343
[No Abstract] [Full Text] [Related]
19. Challenges in immunoscintigraphy of ovarian cancer.
Kim EE; Kasi LP
Gynecol Oncol; 1993 Mar; 48(3):283-4. PubMed ID: 8462895
[No Abstract] [Full Text] [Related]
20. Detection of recurrent colorectal carcinoma with In-111 CYT-103 scintigraphy in a patient with nondiagnostic MRI and CT.
Edlin JP; Kahn D
Clin Nucl Med; 1994 Nov; 19(11):1004-7. PubMed ID: 7842571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
